Log inSign up
Reading a stock page
  • The tabs show the price chart, results, shareholding, events and news for this one company.
  • The Signal Score sums up trend, momentum and quality from past data. It is a description, not a forecast.
  • Every figure names its source. "Official" means it came from NSE or BSE filings.
  • Use the star to watch the stock, or Add to portfolio to record a trade.

Prices during market hours are delayed by up to 15 minutes. Nothing here is a recommendation to buy or sell.

« Dashboard

UNICHEMLAB ☆ NSE also on BSE

UNICHEM LABORATORIES LTD · code 3579 · INE351A01035 · Pharma & Healthcare · series EQ · Daily price history

468.95 -10.30 (-2.15%) close on 20 Nov 2026
Official NSE & BSE Auto-Sync: Checking Overview, Financials, Technicals, Shareholding & Events in the background...
48

ISA Signal Score: Neutral

Hold or watch: no clear edge. Based on prices to 2026-11-20. Confidence 80%.

Trend50
Momentum23
52-week range50
Volume85
Risk54

Working for it

  • Price is above its 200-day average (long-term uptrend)
  • 50-day average is above the 200-day average
  • More volume on up days than down days (accumulation)

Working against it

  • Price is below its 20-day average
  • Price is below its 50-day average
  • 50-day average is falling
  • MACD is negative and weakening

Measured reference levels (not forecasts): 20-day low 468.95, 52-week high 650.60, typical daily move 20.13, two typical moves below price 428.69.

A rule-based reading of price, volume and filed numbers. It is information, not investment advice, and it can be wrong. Do your own research.

At a glance

Five quick readings from results and prices. A starting point for your own research, not advice.
QualityNot knownNeeds the yearly results. They load from NSE on their own for NSE stocks.
GrowthNot knownNeeds the yearly results.
ValuationNot knownNeeds EPS from the yearly results.
MomentumMixedAbove its 200-day average, lagged NIFTY 50 by 0.4 points
RiskHighSwings 51% a year, fell up to 41% from a peak, beta 0.67

Smart Investor Tips: UNICHEMLAB

Balanced / Watch for Key Level Confirmation

Actionable Insights & Positives

  • Pullback within a long-term uptrend: holding above the 200-day average (Rs 446.63) while digesting gains below the 50-day average (Rs 517.03).
  • Tip: Click the star button above to add this stock to your Watchlist and set a target "Buy below" alert price.

NSE MCP Live & 5-Year Check No API Key

Connects directly to NSE's official Model Context Protocol servers (cm-market for live 1–3 min delayed quote & nse-bhavcopy for 52W range, 20/50/200 DMA, 20-day volume surge, and corporate actions), and syncs missing sessions into your database.

Algorithmic Momentum Prediction & Optimal Entry PriceHOLD / POSITIVE ON SUPPORT (Score 68/100)

Consolidating. If buying, accumulate only on dips into support at Rs 460.55 – Rs 468.95 (Ideal ~Rs 464.75). Review if price closes below Rs 417.13; upside resistance near Rs 550.47.

Optimal Support areaTranche 1 (50%)Tranche 2 (50%)Risk level / ReviewLevel 1 (Swing)Level 2 (Breakout)Risk : Reward
Rs 460.55 – Rs 468.95
Ideal ~Rs 464.75
Rs 468.95 Rs 460.55 Rs 417.13
ATR 4.3%
Rs 550.47 Rs 687.20 1 : 1.8
RSI 42 · Vol 2.42x
1M 3M 6M 1Y 3Y ALL Investment checklist Download CSV 3M change -8.6% · high 608.00 · low 460.55 · max drawdown -18.2%

Live Candlestick & TradingView Chart (UNICHEMLAB)

MARKET CLOSED - EOD SNAPSHOT
Style:  Timeframe:  Overlays:

Key figures

P/E-price / earnings
P/B-price / book value
EPS-earnings per share
Dividend yield-from saved dividend events
Debt to equity-borrowings / equity
Sales growth-yearly, needs 2+ years
Profit growth-yearly, needs 2+ years
Operating margin-EBITDA / sales

Yearly results have not loaded yet. They are read from the official NSE results filings on their own; open this page again in a minute.

About UNICHEM LABORATORIES

No company description saved yet. Use Profile below to read about this company.

Listed on BSE NSE

Market capNot available
First listed07 Feb 2001BSE not available · NSE 07 Feb 2001
Face valueRs 2
Book valueNot available
ROENot availableReturn on equity
ROCENot availableReturn on capital employed

NSE: listing date, face value

Profile completeness2 of 8Missing: description, industry, share count, book value, ROE, ROCE

Not checked yet.

Profile, History and Financial records open a web search for this company in a new tab.

Shareholding

Promoters and group 70.22% 0.00 pp, public 29.78%, as on 30 Sep 2026. Holder names and history

Day range465.00 to 477.95Open 472.70
52-week high687.20 -31.8% from high (09 Jul 2026)
52-week low278.20 +68.6% from low (30 Mar 2026)
Volume16,702 0.3x the 20-day average
RSI (14)35 neutral
Volatility (30d)30.6%annualised
278.20
687.20

Returns

1W-6.0%
1M-7.1%
3M-10.9%
6M+26.5%
1Y-1.9%
YTD+6.1%
3Y a year+3.8%
5Y a year+18.2%

Against the NIFTY 50

PeriodUNICHEMLABNIFTY 50Difference
1M-7.1%+13.1% -20.2 pts
3M-10.9%+6.4% -17.3 pts
6M+26.5%+8.8% +17.7 pts
1Y-1.9%-1.5% -0.4 pts

Risk over the past year

Volatility51%high
Deepest fall-40.6%from a peak
Beta0.67moves less than the index
Best day+20.0%08 Jul 2026
Worst day-10.0%22 Jul 2026
Up days44%of sessions

Returns use closing prices. Bonus issues and splits are adjusted automatically when detected. Beta compares daily moves with the NIFTY 50 over 246 shared sessions.

AI analysis

Company turnover, products, risks and entry ideas, written by the AI provider you set up in Settings.

Open AI analysis

Quarterly Results (Last 8 Quarters — QoQ & YoY Acceleration) Rs crore

Rs crore Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales / Revenue 448587527579521575633640
Sales QoQ % +2.5%+31.1%-10.2%+9.9%-10.0%+10.4%+10.1%+1.1%
Operating Profit 74.284.023.065.044.048.070.074.0
Operating Margin (OPM %) 16.6%14.3%4.4%11.2%8.4%8.3%11.1%11.6%
Net Profit (PAT) 46.953.0-10.0-12.026411.041.022.0
Profit QoQ % +8.1%+13.0%-118.9%-20.0%+2300.0%-95.8%+272.7%-46.3%
Profit YoY % -32.3%+146.1%-146.6%-127.7%+463.0%-79.2%+510.0%+283.3%
Net Margin % 10.5%9.0%-1.9%-2.1%50.7%1.9%6.5%3.4%

Financials

Yearly results have not loaded yet.

They are read from the official NSE results filings (XBRL) on their own when this page opens: the newest year first, then up to 5 years over the next visits. If NSE cannot be reached from your host, the line under the company facts says so.

Compared with its sector Pharma & Healthcare

StockPriceDay1 yearMkt cap (Cr)P/EP/BROENet margin
LAURUSLABSLAURUS LABS LIMITED 2,294.60 -0.5% - 123,667 139.4 23.3 16.8% 13.1%
ZYDUSLIFEZYDUS LIFESCIENCES LTD 1,200.00 -0.2% - 120,720 31.5 6.1 0.6% 0.6%
GLENMARKGLENMARK PHARMACEUTICALS 2,648.00 +1.5% - 74,724 - 9.5 -19.1% -12.7%
FORTISFORTIS HEALTHCARE LTD 825.00 +1.9% - 62,284 59.8 - 7.8% 11.7%
GLANDGLAND PHARMA LIMITED 3,331.90 +1.2% - 54,880 53.4 - 8.9% 16.0%
GLAXOGLAXOSMITHKLINE PHARMA LT 2,727.60 +0.5% - 46,208 78.3 26.0 33.2% 17.1%
EMCUREEMCURE PHARMACEUTICALS L 2,337.80 -0.3% - 44,351 47.9 9.0 19.0% 10.2%
SAILIFESAI LIFE SCIENCES LIMITED 1,800.70 +0.7% - 38,250 109.3 15.4 14.0% 15.9%
WOCKPHARMAWOCKHARDT LIMITED 2,184.40 -0.1% - 35,495 166.5 7.2 4.3% 6.4%
GRANULESGRANULES INDIA LIMITED 822.65 +2.7% - 19,939 34.3 3.9 11.7% 11.1%
ALIVUSALIVUS LIFE SCIENCES LTD 1,436.90 -0.9% - 17,609 37.4 7.6 20.2% 20.6%
CAPLIPOINTCAPLIN POINT LAB LTD. 2,029.10 -2.7% - 15,411 33.7 6.7 19.7% 27.0%
Sector median- 50.77.012.4%

The 12 largest of 80 stocks in this sector on NSE, by market cap where known and traded value otherwise. Valuation shows for stocks whose results this site has read; it fills in as people open more stock pages. Prices from 20 Nov 2026.

Today: 15 minute chart and signal

Opens when you view this tab.

Analysis and next-session reading

Opens when you view this tab.

Complete analysis report Financials, shareholding, events, risks and a data reliability score.

Signals

Price is below its 50-day average 20-day average is below the 50-day (short-term downtrend) Price is above its 200-day average (long-term uptrend) RSI 35: neutral

Simple rules applied to end-of-day prices. They describe what the chart is doing and are not advice to buy or sell.

When is a good price? from this stock's own price history

The price is in the lower half of its 1-year range and is lower than it was on 40% of days in the past year.

Support (prices below today's)

20-day low460.55-1.8%
60-day low460.55-1.8%
200-day average446.63-4.8%
52-week low278.20-40.7%

Resistance (prices above today's)

50-day average517.03+10.3%
20-day high542.10+15.6%
60-day high608.00+29.7%
52-week high687.20+46.5%

Zones buyers often watch

Lower quarter of the 1-year range 278.20 to 380.45 Historically the cheapest part of the past year.
Pullback of 10% to 20% from the high 549.76 to 618.48 A common area for dips inside an uptrend.
Around the 200-day average 433.23 to 460.03 Long-term trend line, often watched as support.

Deepest fall from a peak in the past year: -40.6%. Currently -27.9% below its latest peak. Levels are from history and do not predict where the price will go.

Moving averages and momentum

IndicatorValueReading
20-day average491.03 Price is 4.5% below
50-day average517.03 Price is 9.3% below
200-day average446.63 Price is 5.0% above
RSI (14)35Neutral
MACD (12, 26, 9)-10.07Below its signal line (momentum fading)
Volatility (30d)30.6%Medium yearly swings

Support and resistance

R2483.58
R1476.27
Pivot470.63
S1463.32
S2457.68

Classic pivot levels from the latest session's high, low and close. Prices often pause near them, but they are only reference points.

DateOpenHighLow CloseChangeVolume
2026-11-20 472.70 477.95 465.00 468.95 -2.15% 16,702
2026-11-19 478.00 484.80 474.00 479.25 +0.03% 12,709
2026-11-18 474.95 488.00 473.00 479.10 -0.51% 17,306
2026-11-17 488.90 490.00 475.10 481.55 -0.69% 29,319
2026-11-16 494.90 495.15 481.15 484.90 -2.78% 47,042
2026-11-13 500.05 510.00 496.15 498.75 +0.33% 40,490
2026-11-12 505.75 511.85 495.00 497.10 -2.14% 40,918
2026-11-11 510.00 511.80 501.10 507.95 -0.24% 26,948
2026-11-09 501.70 526.95 500.45 509.15 +1.30% 52,161
2026-11-06 485.55 513.00 485.00 501.70 +1.70% 84,039
2026-11-05 508.00 511.90 491.40 493.30 -2.40% 51,211
2026-11-04 508.85 542.10 490.45 505.45 +0.42% 452,254
2026-11-03 503.05 514.65 500.00 503.35 -0.10% 29,571
2026-11-02 483.75 509.00 482.45 503.85 +4.16% 29,023
2026-10-30 504.00 507.25 480.10 483.75 -4.20% 29,181
2026-10-29 488.80 510.00 487.00 504.95 +3.30% 38,035
2026-10-28 489.95 501.85 480.00 488.80 +1.60% 35,539
2026-10-27 477.00 488.95 474.45 481.10 +1.36% 14,310
2026-10-26 468.00 480.00 460.55 474.65 +0.36% 36,103
2026-10-23 481.25 489.00 461.70 472.95 -3.03% 40,084
2026-10-22 509.95 509.95 480.20 487.75 -3.35% 44,302
2026-10-21 502.20 515.00 473.45 504.65 +0.05% 113,058
2026-10-19 510.55 517.00 501.50 504.40 -1.20% 28,397
2026-10-16 523.85 523.85 505.05 510.55 -2.04% 48,083
2026-10-15 522.95 524.95 518.45 521.20 +0.29% 20,421
2026-10-14 530.00 530.00 518.00 519.70 -1.26% 26,429
2026-10-13 530.05 532.50 520.00 526.35 -0.67% 27,657
2026-10-12 530.50 540.95 525.50 529.90 -0.23% 23,650
2026-10-09 534.00 539.50 519.00 531.10 +0.04% 74,517
2026-10-08 548.00 568.95 526.10 530.90 -2.80% 164,167
2026-10-07 552.85 557.90 541.35 546.20 -0.35% 44,644
2026-10-06 531.25 556.20 531.25 548.10 +3.13% 60,230
2026-10-05 536.20 545.00 512.00 531.45 -0.67% 116,755
2026-10-01 542.50 548.90 523.05 535.05 -1.92% 102,131
2026-09-30 569.00 579.20 542.10 545.50 -4.03% 217,861
2026-09-29 537.00 608.00 530.00 568.40 +5.97% 4,127,586
2026-09-28 546.20 558.00 526.60 536.40 -2.42% 117,693
2026-09-25 554.00 559.45 541.35 549.70 -0.53% 50,490
2026-09-24 573.00 582.00 549.80 552.65 -3.59% 156,065
2026-09-23 539.00 576.00 539.00 573.20 +6.39% 294,887
2026-09-22 538.00 566.00 534.70 538.75 -0.35% 114,861
2026-09-21 534.70 554.85 521.55 540.65 -0.93% 72,661
2026-09-18 536.85 547.00 536.85 545.70 +1.35% 26,772
2026-09-17 524.00 554.50 521.20 538.45 +2.71% 82,024
2026-09-16 517.05 530.10 497.80 524.25 +1.00% 65,501
2026-09-15 544.10 548.95 515.00 519.05 -3.83% 57,806
2026-09-11 528.70 544.20 522.05 539.70 +1.31% 59,557
2026-09-10 543.50 549.50 527.55 532.70 -1.84% 73,010
2026-09-09 564.45 564.45 534.15 542.70 -2.32% 94,121
2026-09-08 567.00 575.20 552.40 555.60 -2.48% 72,969
2026-09-07 550.20 591.25 548.00 569.75 +3.55% 309,037
2026-09-04 551.95 557.90 546.55 550.20 +0.41% 56,415
2026-09-03 562.00 569.25 542.85 547.95 -2.09% 73,499
2026-09-02 556.90 579.50 554.40 559.65 +0.59% 155,387
2026-09-01 558.00 573.20 549.45 556.35 -0.04% 192,598
2026-08-31 564.25 589.35 551.40 556.55 -1.36% 321,470
2026-08-28 542.85 570.00 535.00 564.25 +4.54% 330,176
2026-08-27 530.30 545.00 521.20 539.75 +1.78% 102,231
2026-08-26 526.05 548.65 521.05 530.30 +0.81% 81,667
2026-08-25 510.05 555.95 504.05 526.05 +3.19% 819,498
2026-08-24 521.60 531.40 508.50 509.80 -3.11% 44,041
2026-08-21 516.55 533.70 513.50 526.15 +1.86% 65,545
2026-08-20 515.45 524.00 512.05 516.55 +0.71% 78,461
2026-08-19 529.90 529.95 509.00 512.90 -3.15% 84,321

News from the last 15 days More

Shareholding pattern

Up to dateNSE listingChecks passed

Quarter ended 30 Sep 2026, filed 13 Oct 2026. Latest filing is for the expected quarter (Sep 2026). Company: Unichem Laboratories Limited, ISIN INE351A01035.

Promoters and group
70.22%
0.00 pp vs Jun 2026
Public (all, Category B)
29.78%
0.00 pp vs Jun 2026

Foreign, domestic institution and mutual fund lines need the filing file for the period. An admin can load them under Admin > Shareholding tracker.

Ownership split

Trend

Latest quarter compared

CategoryPrevious (Jun 26)Latest (Sep 26)Change (pp)Change in sharesYear earlier (pp)What it may mean
Promoters and group70.22%70.22%0.00 pp-0.00 ppNo material change.
Public (all, Category B)29.78%29.78%0.00 pp-0.00 ppNo material change.

Change is in percentage points (latest percent minus previous percent), not a relative change. Mutual funds and insurers are part of domestic institutions and are never added to it. Only comparable quarters (1 to 6 months apart; about a year for the year-earlier column) are compared.

Insights and risk alerts

No rule was triggered by the data in the database. That is not a clean bill of health: the rules look only at reported holdings.

These alerts describe reported ownership. They are not buy or sell advice. Judge the company with its results, debt, valuation and announcements.

Who holds the shares

Largest holders named in the Sep 2026 filing.

NameTypeShares% of companyLocked-in shares
Ipca Laboratories LimitedBodies Corporate3,70,81,01152.67% -
Dr. Prakash Amrut ModyIndividuals Or HUF89,97,95212.78% -
Hdfc Small Cap FundMutual Funds Or UTI49,58,6457.04% -
Anita Prakash ModyIndividuals Or HUF13,23,4001.88% -
Dsp Healthcare FundMutual Funds Or UTI11,28,6681.60% -
Polunin Emerging Markets Small Cap Fund, LlcInstitutions Foreign Portfolio Investor Two11,08,9561.58% -

Quarter by quarter

Quarter endedPromotersChangePublicChangeFiledSource
Sep 202670.22%0.00 pp29.78%0.00 pp13 Oct 2026
Jun 202670.22%0.00 pp29.78%0.00 pp14 Jul 2026
Mar 202670.22%0.00 pp29.78%0.00 pp13 Apr 2026
Dec 202570.22%0.00 pp29.78%0.00 pp09 Jan 2026
Sep 202570.22%0.00 pp29.78%0.00 pp15 Oct 2025
Jun 202570.22%0.00 pp29.78%0.00 pp19 Jul 2025
Mar 2025 revised70.22%0.00 pp29.78%0.00 pp09 Apr 2025NSE
Dec 202470.22%0.00 pp29.78%0.00 pp09 Jan 2025NSE
Sep 202470.22%0.00 pp29.78%0.00 pp11 Oct 2024NSE
Jun 202470.22%0.00 pp29.78%0.00 pp16 Jul 2024NSE
Mar 202470.22%0.00 pp29.78%0.00 pp12 Apr 2024NSE
Dec 2023 revised70.22%+0.01 pp29.78%-0.01 pp10 Jan 2024NSE
Sep 202370.21%+19.28 pp29.79%-19.28 pp16 Oct 2023NSE
Jun 202350.93%0.00 pp49.07%0.00 pp15 Jul 2023NSE
Mar 202350.93%0.00 pp49.07%0.00 pp12 Apr 2023NSE
Dec 202250.93%0.00 pp49.07%0.00 pp12 Jan 2023NSE
Sep 202250.93%0.00 pp49.07%0.00 pp14 Oct 2022NSE
Jun 202250.93%0.00 pp49.07%0.00 pp18 Jul 2022NSE
Mar 202250.93%0.00 pp49.07%0.00 pp11 Apr 2022NSE
Dec 202150.93%0.00 pp49.07%0.00 pp12 Jan 2022NSE
Sep 202150.93%-49.07%-12 Oct 2021NSE
Shareholding details

Loading...

Events

Not checked yet

No events saved for this stock yet.

Fetched from NSE automatically and saved on this site, so past events stay available. Ex date is the first day the stock trades without the benefit; a bonus or split is applied to old prices on its own from that day. Confirm on the exchange website before acting.

ISA shows information and signals worked out from past prices and company filings. They are not recommendations to buy, sell or hold any security, and ISA is not a SEBI-registered investment adviser or research analyst. Prices may be delayed. Check with a registered adviser before you invest.